Paper

The New KDOQI^TM Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and CKD
Robert G. Nelson^a, Katherine R. Tuttle^b, for the National Kidney Foundation

^aPhoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Ariz., and
^bProvidence Medical Research Center, Spokane, Wash., USA

Address of Corresponding Author

Blood Purif 2007;25:112-114 (DOI: 10.1159/000096407)

  Key Words

• Chronic kidney disease
• Diabetes
• Guidelines, KDOQI

  Abstract

Background/Aims: The National Kidney Foundation (NKF) recently published new guidelines and clinical practice recommendations for the diagnosis and management of patients with diabetes and chronic kidney disease (CKD). Methods: Guidelines were developed using an evidence-based approach. When sufficient evidence was lacking, recommendations were developed that reflect expert opinion. Results: Guidelines describe the process for screening and diagnosis of kidney disease in the setting of diabetes and the management of hyperglycemia, hypertension, dyslipidemia, and nutrition. Recommendations describe the management of albuminuria in the normotensive diabetic patient and the potential value of albuminuria as a marker of treatment efficacy; the impact of diabetes and CKD in special populations; the importance of behavioral self-management; and the value of intensive multifaceted intervention in these high risk patients. Conclusions: The new guidelines and recommendations update and extend the scope of the NKF's Kidney Disease Outcomes Quality Initiative (KDOQI^TM).

Copyright © 2007 S. Karger AG, Basel

  References

1.

Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, Thompson TJ: Projection of diabetes burden through 2050. Diabetes Care 2001;24:1936-1940.

2.

National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39:S1-S266.

3.

US Renal Data System, USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005.

4.

Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. KDOQI, National Kidney Foundation. Am J Kidney Dis 2007;49: in press.

5.

Clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2004;43:S1-S290.

6.

Clinical practice guidelines for managing dyslipidemias in chronic kidney disease. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2003;41:S1-S92.

7.

Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2003;42:S1-S201.

8.

Clinical practice guidelines for anemia of chronic kidney disease: update 2000. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2001;37:S182-S238.

9.

Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000;35:S1-S140.

10.

Clinical practice guidelines for cardiovascular disease in dialysis patients. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2005;45:S1-S153.

  Author Contacts

Dr. Robert G. Nelson
National Institutes of Health
1550 East Indian School Road
Phoenix, AZ 85014-4972 (USA)
Tel. +1 602 200 5205, Fax +1 602 200 5225, E-Mail rgnelson@mail.nih.gov

  Article Information

A similar report was recently published in Nephrology News and Issues (Nelson RG, Tuttle KR: NFK releases new KDOQI guidelines for diabetes and CKD. Nephrol News Issues 2006;20:29.

Published online: December 14, 2006
Number of Print Pages : 3
Number of Figures : 0, Number of Tables : 2, Number of References : 10

  Publication Details

Blood Purification

Vol. 25, No. 1, Year 2007 (Cover Date: December 2006)

Journal Editor: Leunissen, K.M.L. (Maastricht)
ISSN: 0253-5068 (print), 1421-9735 (Online)

For additional information: http://www.karger.com/BPU

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.